Safety and Immunogenicity of a Subunit Trivalent Influenza Vaccine, Northern Hemisphere Formulation 2013/2014, Including MF59C.1 Adjuvant, in Healthy Adults ≥65 Years of Age

Name: Safety and Immunogenicity of a Subunit Trivalent Influenza Vaccine, Northern Hemisphere Formulation 2013/2014, Including MF59C.1 Adjuvant, in Healthy Adults ≥65 Years of Age
License: Public Domain

Novartis Vaccines

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

human influenza

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 158027
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.